Latest News

Findings point toward one of first therapies for Lou Gehrig's disease

Researchers have determined that a copper compound known for decades may form the basis for a therapy for amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease. In humans, prior to this, no therapy for ALS has ever been discovered that could extend lifespan more than a few additional months.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • 'Wikipedia' for neurons created

  • Mother's diet influences weight-control neurocircuits in offspring

  • Rate of opioid misuse is around 25 percent, addiction rate 10 percent, reports study

  • Prototype 'nanoneedles' generate new blood vessels in mice, paving way for new regenerative medicine

  • Component of red grapes, wine could help ease depression

  • Crowdsourced tool for depression

  • Mechanisms that link compulsive binge eating with hypertension identified

  • New link between neurodegenerative diseases, abnormal immune responses found

  • Super sensitive measurement of magnetic fields

  • Family income, parental education related to brain structure in children, adolescents

  •